Reginald Love

CIK: 0001749370

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SRTA

Strata Critical Medical, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

SRTA
Strata Critical Medical, Inc.
Aug 10, 2026
Sale(S)
Direct
5.1K shares at avg. $5.75$29K
SRTA
Strata Critical Medical, Inc.
Jul 30, 2026
Award(A)
Direct
37.7K shares-
SRTA
Strata Critical Medical, Inc.
Nov 20, 2025
Sale(S)
Direct
11K shares at avg. $4.37$48K
SRTA
Strata Critical Medical, Inc.
Nov 19, 2025
Sale(S)
Direct
11K shares at avg. $4.31$47K
BLDE
Blade Air Mobility, Inc.
Aug 1, 2025
Award(A)
Direct
35.5K shares-
BLDE
Blade Air Mobility, Inc.
Dec 13, 2024
Sale(S)
Direct
5.1K shares at avg. $4.05$21K

		Type	Shares	Price		Ownership
Aug 10, 2026	SRTA Strata Critical Medical, Inc.	Sale(S)	5,091	$5.75	$29,273	Direct
Jul 30, 2026	SRTA Strata Critical Medical, Inc.	Award(A)	37,675	-	$0	Direct
Nov 20, 2025	SRTA Strata Critical Medical, Inc.	Sale(S)	11,000	$4.37	$48,070	Direct
Nov 19, 2025	SRTA Strata Critical Medical, Inc.	Sale(S)	11,000	$4.31	$47,434	Direct
Aug 1, 2025	BLDE Blade Air Mobility, Inc.	Award(A)	35,534	-	-	Direct
Dec 13, 2024	BLDE Blade Air Mobility, Inc.	Sale(S)	5,091	$4.05	$20,619	Direct

1-6 of 6 transactions

About Love Reginald

Love Reginald (SEC CIK 0001749370) files insider reports with the SEC as Director of Strata Critical Medical, Inc. (SRTA).

Signal8 holds 6 ownership filings by Love Reginald, all Form 4s, filed between Dec 17, 2024 and Aug 13, 2026. Those filings report 6 transactions, from Dec 13, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Love Reginald's filings is in NEW YORK, NY.

Recent filings by Love Reginald

Aug 10, 2026: Open-market sale of SRTA shares (Form 4, code S).
Jul 30, 2026: Grant or award of SRTA shares (Form 4, code A).
Nov 20, 2025: Open-market sale of SRTA shares (Form 4, code S).
Nov 19, 2025: Open-market sale of SRTA shares (Form 4, code S).
Aug 1, 2025: Grant or award of BLDE shares (Form 4, code A).

Other insiders filing for Strata Critical Medical, Inc. (SRTA)

Wunsch Scott M, CEO, Logistics
Tomkiel Melissa M., Co-CEO and General Counsel
Heyburn William A., Co-CEO and CFO
Verdetto Louis R., CEO, Clinical Services
Cohen Amir, Chief Accounting Officer
Cook William L. III, Director

How to read Form 4 transaction codes